IPP Bureau
Granules India received ANDA approval for Guaifenesin and Pseudoephedrine Hydrochloride ER
By IPP Bureau - August 27, 2022
Granules now have a total of 51 ANDA approvals from US FDA (49 Final approvals and 2 tentative approvals).
US FDA inspection at Gland Pharma's Dundigal facility, Hyderabad
By IPP Bureau - August 26, 2022
The company has received 1 (ONE) observation on Form 483 with respect to ANDA filed for the product to be manufactured at the said Facility.
Lupin and I'rom signs licensing agreement for Denosumab biosimilar for Japan
By IPP Bureau - August 26, 2022
10th Merck Bioforum India 2022 on Sept. 6-8
By IPP Bureau - August 26, 2022
This Bioforum will provide the latest insights on delivering increased speed, greater flexibility and enhanced quality while reducing the cost, and risks of navigating the evolving biopharma landscape
JB Pharma ranks 23 in Indian pharma market
By IPP Bureau - August 26, 2022
JB Pharma is the fastest growing pharmaceutical company in FY 2021-22 and Q1 of FY 2022-23.
ENTOD organising nationwide campaign to encourage people to donate eyes
By IPP Bureau - August 26, 2022
The initiative aims to reach out to more than 20 million people across the country and a number of social media influencers have also pledged to extend their whole-hearted support for the noble cause
Pristyn Care witnesses industry highest adoption of EMR
By IPP Bureau - August 26, 2022
99% of Pristyn Doctors are using EMR facility on its doctor app
Olaparib approved in Japan as adjuvant treatment for patients with high recurrent risk breast cancer
By IPP Bureau - August 26, 2022
First and only PARP inhibitor to improve invasive disease-free survival, the primary endpoint, and overall survival, a key secondary endpoint of the OlympiA trial, in these patients
Lupin receives approval from US FDA for Formoterol Fumarate Inhalation Solution
By IPP Bureau - August 25, 2022
Formoterol Fumarate Inhalation Solution (RLD Perforomist) had estimated annual sales of US $282 million in the US
Lupin to acquire brands Ondero and Ondero - Met from Boehringer Ingelheim
By IPP Bureau - August 25, 2022
The cash consideration for the above acquisition will be Euro 26 million.
3Brain AG's Accura-3D microchip, enters the market
By IPP Bureau - August 24, 2022
3D CMOS chip for connecting electroactive tissues and organoids to software
Merck gets fast track designation from the USFDA for anticoagulant therapy
By IPP Bureau - August 24, 2022
Phase 2 Study of MK-2060 Currently Ongoing in People with End-Stage Renal Disease Receiving Hemodialysis
Dozee and Midmark to launch India’s first intelligent connected bed with Remote Patient Monitoring and EWS
By IPP Bureau - August 24, 2022
The intelligent connected bed is one of the most significant breakthroughs in India’s journey to create a world-class connected healthcare system to deliver quality healthcare to a billion Indians.
Nursing and Midwifery associations call out the urgent need for policy support to drive a robust health workforce in India
By IPP Bureau - August 24, 2022
Today, India stands at 1.7 nurses per 1,000 population, as opposed to the World Health Organization norm of 3 nurses per 1000.
Mojocare secures US$20.6 million in Series A Funding
By IPP Bureau - August 24, 2022
The funding round also saw participation from some of India's top angel investors and leading industry giants
